SABBY MANAGEMENT, LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is and the CUSIP is 37890U908. A total of 3 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2018$4,986,000
+31.9%
1,312
+56.9%
0.64%
+9.2%
Q2 2018$3,779,000
-48.4%
836
-44.9%
0.58%
+33.6%
Q1 2018$7,322,000
+683.1%
1,516
+403.7%
0.44%
+616.4%
Q3 2017$935,000
-49.0%
301
-55.1%
0.06%
-49.2%
Q2 2017$1,832,000
+22.8%
670
+65.4%
0.12%
+50.0%
Q1 2017$1,492,000
-10.2%
405
-43.8%
0.08%
+29.0%
Q3 2016$1,662,000
+138.1%
721
+71.3%
0.06%
+72.2%
Q2 2016$698,000
-92.2%
421
-92.5%
0.04%
-91.9%
Q1 2016$8,924,0005,6270.45%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2016
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,312$4,986,0000.64%
BOOTHBAY FUND MANAGEMENT, LLC 228$866,0000.09%
GROUP ONE TRADING, L.P. 124,400$4,727,0000.04%
SIMPLEX TRADING, LLC 421$1,599,0000.01%
JPMORGAN CHASE & CO 149,900$5,696,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders